Imagen de Portada

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Xiang‐Sha Yin, Jianru Sun, Xue Wang, Wei Wu, Zhen Chen, Di Zhang, Yuanyuan Xu, Yongmei Chen, Wenying Qiu, Xiaojing Qian, Jun Ni, Chao Ma
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Input of exome sequencing in early‐onset cerebral amyloid angiopathy
por: Lou Grangeon, et al.
Publicado: (2024)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
por: Yuhan Xie, et al.
Publicado: (2025)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
por: Soheil Mohammadi, et al.
Publicado: (2025)

White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
por: Antoine Garnier‐Crussard, et al.
Publicado: (2026)

Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort
por: Joyce R. Chong, et al.
Publicado: (2024)

Intracranial arteriosclerosis is not associated with cerebral amyloid deposition
por: Anna M. Streiber, et al.
Publicado: (2024)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
por: Faheem Arshad, et al.
Publicado: (2025)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
por: Alisa Bannerjee, et al.
Publicado: (2025)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
por: Sofia Toniolo, et al.
Publicado: (2024)

Blood phosphorylated Tau181 reliably differentiates amyloid‐positive from amyloid‐negative subjects in the Alzheimer's disease continuum: A systematic review and meta‐analysis
por: Annibale Antonioni, et al.
Publicado: (2025)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
por: Ying Xia, et al.
Publicado: (2025)

Investigating the amyloid–tau–neurodegeneration framework in Alzheimer's disease using semi‐supervised multimodal imaging data fusion
por: You Cheng, et al.
Publicado: (2026)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
por: Jacqueline Chua, et al.
Publicado: (2025)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
por: María A. Rodríguez‐Santiago, et al.
Publicado: (2024)

Divergent effects of age on imaging‐based ATN biomarkers and cognition in Alzheimer's disease
por: Lars Frings, et al.
Publicado: (2025)

Identifying cognitive test scores associated with early tau burden in Alzheimer's disease
por: Caitlin M. Terao, et al.
Publicado: (2025)

Validation of regression‐based change formulae for mild cognitive impairment and Alzheimer's disease
por: Kevin Duff, et al.
Publicado: (2024)

Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive decline
por: Stefan J. Teipel, et al.
Publicado: (2024)

Motor, not cognitive, performance relates to amyloid status in normal older adults
por: Amanda Cook Maher, et al.
Publicado: (2026)

Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid‐positive and amyloid‐negative groups from Japanese trial‐ready cohort study
por: Saki Nakashima, et al.
Publicado: (2026)

The impact of amyloid beta burden on white matter dysfunction and associated transcriptomic signatures in cognitively normal elderly individuals
por: Ziyun Li, et al.
Publicado: (2025)

Comparison of three plasma p‐tau217 assays to detect PET‐confirmed Alzheimer's pathologies
por: Sayo Matsuura, et al.
Publicado: (2026)

Deep medullary vein abnormalities associated with cognitive function and Alzheimer's disease plasma biomarkers in dementia‐free older adults: A population‐based study
por: Dejia Yin, et al.
Publicado: (2026)

Inner and outer retinal abnormalities detected in Alzheimer's disease subjects diagnosed by amyloid PET not revealed when classified based on clinical criteria
por: Leonardo E. Ariello, et al.
Publicado: (2025)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
por: Miguel Ángel Rivas‐Fernández, et al.
Publicado: (2026)

Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults
por: Ihab Hajjar, et al.
Publicado: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
por: Juliana N. Souza‐Talarico, et al.
Publicado: (2025)

BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease
por: Kyle J. Edmunds, et al.
Publicado: (2025)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
por: Alexandra Paget‐Blanc, et al.
Publicado: (2025)

Retinal vascular biomarkers in mild cognitive impairment and Alzheimer's disease: a comprehensive review and meta‐analysis
por: Sunu Mathew, et al.
Publicado: (2025)

Novel insights into early Alzheimer's disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathology
por: Satya V. V. N. Kothapalli, et al.
Publicado: (2026)

Generative diffusion model enables quantification of calibration‐free arterial spin labeling perfusion magnetic resonance imaging data in an Alzheimer's disease cohort
por: Qinyang Shou, et al.
Publicado: (2025)

Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers
por: Rachel R. Jin, et al.
Publicado: (2025)

The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
por: Angela van der Putten‐Toorenburg, et al.
Publicado: (2026)

A systematic review and meta‐analysis of basal microbiota and cognitive function in Alzheimer's disease: A potential target for treatment or a contributor to disease progression?
por: Ana Maria Jimenez‐García, et al.
Publicado: (2024)

Association of apolipoprotein E genotype with cognitive performance: findings from the University of California, Davis Alzheimer's Disease Research Center longitudinal diversity cohort
por: Eva Min, et al.
Publicado: (2026)

Eye tracking as a diagnostic tool in Alzheimer's disease, mild cognitive impairment, and related dementias: a systematic review
por: Gustavo Luis Verón, et al.
Publicado: (2025)

Prevalence and predictors of diagnosed mild cognitive impairment among Medicare beneficiaries
por: Elyse Couch, et al.
Publicado: (2025)

Online46: Online cognitive assessments in elderly cohorts—The British 1946 birth cohort case study
por: Ziyuan Cai, et al.
Publicado: (2025)

Age‐related macular degeneration severity and risk of Alzheimer's disease in older adults in a prospective, community‐based cohort study
por: Chloe A. Krakauer, et al.
Publicado: (2026)